Treatment beyond progression with nivolumab (nivo) in patients (pts) with advanced renal cell carcinoma (aRCC) in the phase III CheckMate 025 study Meeting Abstract
| Authors: | Escudier, B.; Motzer, R. J.; Sharma, P.; Wagstaff, J.; Plimack, E. R.; Hammers, H. J.; Donskov, F.; Gurney, H.; Sosman, J. A.; Zalewski, P.; Harmenberg, U.; McDermott, D. F.; Choueiri, T. K.; Richardet, M. E.; Tomita, Y.; Ravaud, A.; Doan, J.; Zhao, H.; Hardy, H.; George, S. |
| Abstract Title: | Treatment beyond progression with nivolumab (nivo) in patients (pts) with advanced renal cell carcinoma (aRCC) in the phase III CheckMate 025 study |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 246s |
| Language: | English |
| ACCESSION: | WOS:000404665407082 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.4509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4509 -- Source: Wos |
